Table 1.
Male/female [n (%)] | 53 (62)/32 (38) |
Mean age [years (range)] | 49 (18–80) |
Co-morbidity [n (%)] | 26 (31) |
Cardiovascular | 6 (7) |
Pulmonary | 3 (4) |
Neurological | 1 (1) |
Rheumatological | 4 (5) |
Haematological | 1 (1) |
Depression | 3 (4) |
Diabetes | 5 (6) |
Other | 3 (4) |
Immunocompromised [n (%)] | 1 (1) |
Vascular graft [n (%)] | 1 (1) |
Antibiotic treatment [n (%)] | |
Doxycycline | 5 (6) |
Moxifloxacin | 35 (41) |
Beta-lactam antibiotic | 32 (38) |
Azithromycin | 1 (1) |
None | 12 (14) |
Mortality due to Q fever | 0 (0) |
Overall one-year mortality | 1 (1) |
Hospitalisation [n (%)] | 24 (28) |
Pneumonia severity index (PSI) of hospitalised patients | |
PSI class I | 12 (50) |
PSI class II | 8 (33) |
PSI class III | 4 (17) |
PSI class IV and class V | 0 (0) |
Intensive care treatment | 0 (0) |
Duration of hospitalisation (days, median) | 4 (5) |